INPATIENT DECOMPENSATED CHRONIC LIVER DISEASE: EPIDEMIOLOGY AND HOSPITAL OUTCOMES IN TERTIARY CARE

Authors

  • M Asim Hamza Countess Of Chester Hospital, Health Education England, UK Author
  • Jamal Shah Royal Blackburn Hospital, City, UK Author
  • Irfan Ullah Central Hospital Sharjah, UAE Author

Keywords:

Decompensated chronic liver diseases, Epidemiology, DCLD, Disease outcome

Abstract

Background: decompensated chronic liver disease (DCLD) is the leading cause of global mortality and morbidity with varied aetiological factors and inconsistent outcomes. Extensive literature exists on its clinical and management aspects, but little on epidemiological outcomes; therefore, this study aims to characterise the epidemiology and hospital outcomes of patients admitted with DCLD in a tertiary care hospital. Methods: This analytical cross-sectional study was conducted at Khyber Teaching Hospital & Hayat Medical Complex from March 2019 to April 2021 among adult inpatients with confirmed cirrhosis. Data on demographic and disease characteristics were recorded and analysed using SPSS-26. The primary outcome, i.e., discharge status (improved vs. died), was tested using independent t-tests and chi-square/Fisher’s exact tests with p<0.05. Results: A total of 61 diagnosed cases of DCLD, male 36 (59%), with an overall mean age of 49.61±14.028 years, a mean duration of disease of 3.94±3.649 years, and 4.02±1.576 days of LOS were included. The mortality rate of in-patient DCLD patients was 12 (19.7%). Only aetiology was significantly associated with patient outcomes. Patients who improved had a longer hospital stay. Conclusion: Outcomes in DCLD are strongly influenced by non-clinical forces. Social class was more important in predicting death than clinical factors, while gender and disease duration mattered less than expected. The high death rate from Hepatitis C needs immediate action to improve access to care. Also, staying longer in the hospital may help save lives by allowing better management of complications.

Author Biographies

  • M Asim Hamza, Countess Of Chester Hospital, Health Education England, UK

    Gastroenterology, Hepatology and Internal Medicine, MRCP Specialist Registrar 

  • Jamal Shah, Royal Blackburn Hospital, City, UK

    Medical Registrar Internal Medicine MBBS FCPS MRCP UK, MRCP Ire, Medical Registrar

  • Irfan Ullah, Central Hospital Sharjah, UAE

    Internal Medicine, MBBS, FCPS(cc), Junior Registrar

References

Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol 2023;79(2):516–37. DOI: https://doi.org/10.1016/j.jhep.2023.03.017

Battle A, Mudd J, Ahlenstiel G, Kalo E. Liver cirrhosis: Evolving definitions, and recent advances in diagnosis, prevention and management. Livers 2025;5(3):28. DOI: https://doi.org/10.3390/livers5030028

Gustot T, Stadlbauer V, Laleman W, Alessandria C, Thursz M. Transition to decompensation and acute-on-chronic liver failure: Role of predisposing factors and precipitating events. J Hepatol 2021;75;S36–48. DOI: https://doi.org/10.1016/j.jhep.2020.12.005

Cheemerla S, Balakrishnan M. Global Epidemiology of Chronic Liver Disease. Clin Liver Dis (Hoboken). 2021;17(5):365–70. DOI: https://doi.org/10.1002/cld.1061

Mohammadi M, Hasjim BJ, Balbale SN, Polineni P, Huang AA, Paukner M, et al. Disease trajectory and competing risks of patients with cirrhosis in the US. PLoS One 2025;20(2):e0313152. DOI: https://doi.org/10.1371/journal.pone.0313152

Mallik M, Singhai A, Khadanga S, Ingle V. The significant morbidity and mortality indicators in patients of cirrhosis. Cureus 2022;14(1):e21226. DOI: https://doi.org/10.7759/cureus.21226

Bhattarai S. Complications and mortality in hospitalised patients with decompensated cirrhosis of liver in a tertiary care centre in Nepal. Cureus 2020;12(8):e9996. DOI: https://doi.org/10.7759/cureus.9996

Fleming KM, Aithal GP, Card TR, West J. All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study. Liver Int 2012;32(1):79–84. DOI: https://doi.org/10.1111/j.1478-3231.2011.02517.x

Ifrah A, Fromer R, Gayner AH, Yeung HM. Discharge outcomes of hospitalized patients with new onset decompensated cirrhosis. Dig Dis Sci 2024;69(9):3220–5. DOI: https://doi.org/10.1007/s10620-024-08574-8

Tapper EB, Parikh ND. Diagnosis and management of cirrhosis and its complications: a review. JAMA 2023;329(18):1589–1602. DOI: https://doi.org/10.1001/jama.2023.5997

Salim A, Farooq MO, Saleem S, Malik K. Financial burden and social implications of chronic liver disease in a patient population group in Pakistan. Pak J Med Sci 2024;40(7):1503–8. DOI: https://doi.org/10.12669/pjms.40.7.7976

Golembiewski E, Allen KS, Blackmon AM, Hinrichs RJ, Vest JR. Combining nonclinical determinants of health and clinical data for research and evaluation: rapid review. JMIR Public Health Surveill 2019;5(4):e12846. DOI: https://doi.org/10.2196/12846

Khosravizadeh O, Vatankhah S, Bastani P, Kalhor R, Alirezaei S, Doosty F. Factors affecting length of stay in teaching hospitals of a middle-income country. Electron Physician 2016;8(10):3042–7. DOI: https://doi.org/10.19082/3042

Askgaard G, Fleming KM, Crooks C, Kraglund F, Jensen CB, West J, et al. Socioeconomic inequalities in the incidence of alcohol-related liver disease: A nationwide Danish study. The Lancet Reg Health Eur 2021;8:100172. DOI: https://doi.org/10.1016/j.lanepe.2021.100172

Collis D. Social grade: A classification tool. Ipsos Media CT; 2009. [cited 2025 Jun 28]. Available from: https://www.ipsos.com/sites/default/files/publication/6800-03/MediaCT_thoughtpiece_Social_Grade_July09_V3_WEB.pdf

Mukerji AN, Patel V, Jain A. Improving survival in decompensated cirrhosis. Int J Hepatol 2012;2012:318627. DOI: https://doi.org/10.1155/2012/318627

Shah AS, Amarapurkar DN. Natural history of cirrhosis of liver after first decompensation: a prospective study in India. J Clin Exp Hepatol. 2018;8(1):50–7. DOI: https://doi.org/10.1016/j.jceh.2017.06.001

Khan HA, Din NU, Iqbal S, Abbas G, Yousaf M, Shah BM, Umam S. Mortality and length of hospital stay in patients with liver cirrhosis based on their meld score: retracted article. Journal of Medical Sciences. 20224; 32(1):12–17. DOI: https://doi.org/10.52764/jms.24.32.1.2

Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019 Jan;70(1):151-171. DOI: https://doi.org/10.1016/j.jhep.2018.09.014

Mazumder NR, Celaj S, Atiemo K, Daud A, Jackson KL, Kho A, Levitsky J, Ladner DP. Liver-related mortality is similar among men and women with cirrhosis. J Hepatol. 2020 Nov;73(5):1072-1081. DOI: https://doi.org/10.1016/j.jhep.2020.04.022

Mellinger, Jessica L. High 10-year mortality in alcohol-related liver disease: where do we go from here? The Lancet Gastroenterology & Hepatology2023.8( 11): 961 – 962.

Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012 Feb;107(2):247-52. DOI: https://doi.org/10.1038/ajg.2011.314

Samonakis DN, Koulentaki M, Coucoutsi C, Augoustaki A, Baritaki C, Digenakis E, et al. Clinical outcomes of compensated and decompensated cirrhosis: A long term study. World J Hepatol. 2014 Jul 27;6(7):504-12. DOI: https://doi.org/10.4254/wjh.v6.i7.504

Verna EC, Morelli G, Terrault NA, Lok AS, Lim JK, Di Bisceglie AM, et al. DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort. J Hepatol. 2020 Sep;73(3):540-548. DOI: https://doi.org/10.1016/j.jhep.2020.03.031

Qazi Arisar FA, Kamran M, Nadeem R, Jafri W. Impact of severity of chronic liver disease on health-related economics. Hepat Mon 2020;20(6):e97933. DOI: https://doi.org/10.5812/hepatmon.9793

Kardashian A, Serper M, Terrault N, Nephew LD. Health disparities in chronic liver disease. Hepatology 2023;77(4):1382–403. DOI: https://doi.org/10.1002/hep.32743

Al-Smadi K, Qureshi A, Buitrago M, Ashouri B, Kayali Z. Survival and Disease Progression in Older Adult Patients With Cirrhosis: A Retrospective Study. Int J Hepatol 2024;2024:5852680. DOI: https://doi.org/10.1155/2024/5852680

Khan HA, Din NU, Iqbal S, Abbas G, Yousaf M, Shah BM, Umam S. Mortality and length of hospital stay in patients with liver cirrhosis based on their meld score: retracted article. J Med Sci 2024;32(1):12–7. DOI: https://doi.org/10.52764/jms.24.32.1.2

Second issue

Downloads

Published

12/31/2025

Issue

Vol. 1 No. 2 (2025): Online

Section

Original Articles

License

Copyright (c) 2026 M Asim Hamza, Jamal Shah, Irfan Ullah (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

All articles and/or materials are published under the CC BY-ND 4.0 International License, which permits sharing and redistribution in any medium or format, provided the work remains unchanged and is correctly attributed to the original authors and MedPulse Spectrum.

How to Cite

INPATIENT DECOMPENSATED CHRONIC LIVER DISEASE: EPIDEMIOLOGY AND HOSPITAL OUTCOMES IN TERTIARY CARE. (2025). MedPulse Spectrum, 1(2), 13-17. https://jouex.com/index.php/medpulspect/article/view/26